Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;12(4):e147-50.
doi: 10.1016/j.clgc.2014.02.006. Epub 2014 Feb 28.

Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature

Mehmet Asim Bilen  1 , Houssam Hariri  2 , Chady Leon  3 , Charles C Guo  4 , Deborah A Kuban  5 , Louis L Pisters  6 , Shi-Ming Tu  7
Affiliations
Review

Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature

Mehmet Asim Bilen et al. Clin Genitourin Cancer. 2014 Aug.
No abstract available

Keywords: False-positive; Fluorine-18 deoxyglucose positron-emission tomography–computed tomography scan; Inflammatory changes; Seminomatous germ cell tumor; Testicular cancer.

PubMed Disclaimer

Conflict of interest statement

Disclaimers: The authors have stated that they have no conflicts of interest.

Figures

Figure 1
Figure 1
CT of the abdomen revealed retroperitoneal mass (arrow).
Figure 2
Figure 2
FDG-PET/CT scanning revealed a retroperitoneal mass, with maximal SUV of 10.9 (arrow) (A) transverse image and (B) full-body image.
Figure 2
Figure 2
FDG-PET/CT scanning revealed a retroperitoneal mass, with maximal SUV of 10.9 (arrow) (A) transverse image and (B) full-body image.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Peckham MJ, Horwich A, Hendry WF. Advanced seminoma: Treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8) Br J Cancer. 1985;52:7–13. - PMC - PubMed
    1. Puc HS, Heelan R, Mazumdar M, et al. Management of residual mass in advanced seminoma: Results and recommendations from the Memorial Sloan-Kettering Cancer Center. J Clin Oncol. 1996;14:454–460. - PubMed
    1. Flechon A, Bompas E, Biron P, et al. Management of post-chemotherapy residual masses in advanced seminoma. J Urol. 2002;168:1975–1979. - PubMed
    1. Herr HW, Sheinfeld J, Puc HS, et al. Surgery for a post-chemotherapy residual mass in seminoma. J Urol. 1997;157:860–862. - PubMed
    1. Schultz SM, Einhorn LH, Conces DJ, Jr, et al. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol. 1989;7:1497–1503. - PubMed

Substances